# MY01

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/my01

- Industry: Medical Devices & Equipment
- Headquarters: Montreal, Canada
- Website: www.my01.io
- Total disclosed funding: $9.3M
- Latest round: Series A (Apr 11, 2023)
- Investors on record: 3

## About

Based in Quebec, Canada, and founded in 2015 by CEO Charles Allan, CTO George Xereas, and CMO Ed Harvey, MY01 Inc. operates as a health-tech company that uses microsensors to translate continuous pressure data to both a monitor and a mobile app for diagnosing acute compartment syndrome (ACS). In April 2023, MY01, Inc. raised CAD 12.5 million in Series A funding led by Investissement Québec, with participation from other Desjardins Capital and Fondaction.

MY01 Inc. provides Digital micro sensing technology, which helps monitor the pressure in the muscle compartments of patients. The company offers quantitative data for customized treatment and conducts the assessment of patient's health status. In addition, the firm provides medical equipment for the detection of Compartment Syndrome (CS), which is a medical condition where pressure increases inside a muscle, which restricts blood flow and causes pain. The company provides a mobile application for smartphone users to monitor the diagnosis condition of patients.

## Funding rounds

- Series A, Apr 11, 2023, $9.3M — Investment Quebec, Fondaction, Desjardins Capital

## Investors

- Investment Quebec (https://capitalatlas.ai/funds/investment-quebec) — Series A
- Fondaction (https://capitalatlas.ai/funds/fondaction) — Series A
- Desjardins Capital (https://capitalatlas.ai/funds/desjardins-capital) — Series A